Related references
Note: Only part of the references are listed.Imatinib Mesylate as a Preoperative Therapy in Dermatofibrosarcoma: Results of a Multicenter Phase II Study on 25 Patients
Delphine Kerob et al.
CLINICAL CANCER RESEARCH (2010)
Connecting autophagy to senescence in pathophysiology
Andrew R. J. Young et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
Piotr Rutkowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
No Correlation between the Molecular Subtype of COL1A1-PDGFB Fusion Gene and the Clinico-Histopathological Features of Dermatofibrosarcoma Protuberans
Damien Giacchero et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas†
Elena Tamborini et al.
NEURO-ONCOLOGY (2010)
Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST)
Anu Gupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma
Silvia Stacchiotti et al.
CLINICAL CANCER RESEARCH (2009)
PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor
Federica Perrone et al.
NEURO-ONCOLOGY (2009)
Cutaneous soft tissue sarcoma incidence patterns in the US - An analysis of 12,114 cases
Panta Rouhani et al.
CANCER (2008)
Dermatofibrosarcoma protuberans
Vassilios A. Dimitropoulos
DERMATOLOGIC THERAPY (2008)
Value of cytogenetic analysis in the treatment of dermatofibrosarcoma protuberans
Delphine Kerob et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Is Autophagy Rather Than Apoptosis the Regression Driver in Imatinib-Treated Gastrointestinal Stromal Tumors?
Francesca Miselli et al.
TRANSLATIONAL ONCOLOGY (2008)
Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002
Vincent D. Criscione et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibrornatosis
Stefano Signoron et al.
CLINICAL CANCER RESEARCH (2007)
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma
Lisa Licitra et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma
Federica Perrone et al.
CLINICAL CANCER RESEARCH (2006)
Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp
Bernd Kasper et al.
ANTI-CANCER DRUGS (2006)
The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans
JJ Abbott et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Dermatofibrosarcoma protuberans treated at a single institution: A surgical disease with a high cure rate
M Fiore et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate
SV Labropoulos et al.
ANTI-CANCER DRUGS (2005)
Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib target exploration consortium study B2225
GA McArthur et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer
E Tamborini et al.
CLINICAL CANCER RESEARCH (2004)
Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS
H Saeki et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2003)
Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans
BP Rubin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans
RG Maki et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans
S Kiuru-Kuhlefelt et al.
CYTOGENETICS AND CELL GENETICS (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans
J Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2000)
Share Paper
